0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Hypertension, Exercise, and Beta-Adrenergic Blockade

Philip A. Ades, MD; Peter G.S. Gunther, MD; Cathy P. Meacham, RN; Mary A. Handy, RPT; and Martin M. LeWinter, MD
[+] Article and Author Information

Grant Support: Partial support by grant RR109 from the General Research Center and a grant from CIBA-Geigy Pharmaceuticals, Summit, New Jersey.

Requests for Reprints: Philip A. Ades, MD, Division of Cardiology, McClure 1, Medical Center Hospital of Vermont, Burlington, VT 05401.

Current Author Addresses: Drs. Ades and LeWinter: Division of Cardiology, McClure 1, Medical Center Hospital of Vermont, Burlington, VT 05401.

Dr. Gunther and Ms. Handy: 1 S. Prospect Street, Burlington, VT 05401.

Ms. Meacham: 5333 S. Bear Creek Drive, Merced, CA 95340.


© 1988 American College of PhysiciansAmerican College of Physicians


Ann Intern Med. 1988;109(8):629-634. doi:10.7326/0003-4819-109-8-629
Text Size: A A A

Study Objective: To determine whether beta-adrenergic blocking agents affect exercise tolerance, exercise conditioning response, and blood pressure response to conditioning in hypertensive patients.

Design: Randomized, double-blinded, placebo-controlled trial with a 10-week exercise period.

Setting: Outpatient, monitored exercise program at a community-based, university-sponsored cardiac rehabilitation facility.

Patients: Thirty adults with mean resting blood pressure of 145 mm Hg or greater (systolic), 95 mm Hg or greater (diastolic), or a combined systolic and diastolic pressure of 140/90 mm Hg or greater. Mean systolic pressure of 170 mm Hg or more or mean diastolic pressure of 105 mm Hg or more was exclusionary. Mean blood pressure was 145/95 mm Hg; mean age was 46.5 years.

Intervention: The beta-1-nonselective blocker was propranolol, 80 mg twice daily. The beta-1-selective blocker was metoprolol, 100 mg twice daily, compared with placebo. All patients did exercise conditioning consisting of 40 sessions of aerobic exercise with heart rate monitoring.

Measurements and Main Results: Resting systolic blood pressure measured without drug therapy was lowered markedly after exercise conditioning on placebo (146 to 135 mm Hg) and on metoprolol (144 to 133 mm Hg) (P < 0.05), but not on propranolol (no change). Acutely, propranolol decreased both maximal oxygen consumption (VO2max) and exercise duration compared with metoprolol and placebo. Chronically, VO2max increased 24% (95% CI, 8 to 40) in response to training on placebo and 8% on metoprolol (95% CI, 3 to 14); it did not increase on propranolol (95% CI, -10 to 15).

Conclusions: If an exercise program is to be recommended as an adjunct to pharmacologic beta-blockade for hypertension, blood-pressure-lowering effects are preserved and exercise capacity is less affected with a beta-1-selective agent than with a beta-1-nonselective agent. Antihypertensive medications may be avoided altogether for selected patients who sustain an aerobic exercise program.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)